Is it Clinically appropriate to take someone that is on the injectable which is Inqovi to switch to two oral forms instead (from injection TO two drugs) (CLINICAL IMPORTANCE) of switching someone from the injectable (Inqovi) to the oral form which will be the two drugs (decitabine and cedazuride ) taken separately in oral forms. The Pros and cons of switching someone from the inhectable form to the oral form?
Question 2 : Does the Injection form of Inqovi have any medical benefits? IF yes, what are those benefits?
Question 3: Can you look up some information on Medicare reinsurance program–> maybe specific to oncology
